GSI 7916 (Epclusa sofosbuvir 400 mg / velpatasvir 100 mg)
Generic Name: sofosbuvir/velpatasvir
Pill imprint GSI 7916 has been identified as Epclusa sofosbuvir 400 mg / velpatasvir 100 mg.
Epclusa is used in the treatment of hepatitis c and belongs to the drug class antiviral combinations. Epclusa sofosbuvir 400 mg / velpatasvir 100 mg is classified as a Schedule U controlled substance under the Controlled Substance Act (CSA).
More about Epclusa (sofosbuvir / velpatasvir)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 30 Reviews – Add your own review/rating
- Drug class: antiviral combinations
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.